Tempus AI insider files Form 144 for 7,528 NASDAQ shares; prior 10b5-1 sale noted

Rhea-AI Filing Summary

Tempus AI, Inc. insider filings show a proposed sale of 7,528 Class A common shares through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $590,571.60. The shares were granted as restricted stock units between 04/21/2021 and 05/02/2024 in multiple tranches totaling the amounts listed. The filer previously sold 23,121 shares under a 10b5-1 plan on 05/20/2025 for gross proceeds of $1,462,779.51. The notice includes the standard signature representation that no undisclosed material adverse information is known.

Positive

• Transparent disclosure of proposed sale details including broker, share count, and market value
• Use of 10b5-1 sales for at least one prior transaction (05/20/2025), indicating preplanned selling and compliance with trading rules

Negative

• Insider selling activity: proposed sale of 7,528 shares and a prior sale of 23,121 shares may be viewed negatively by some investors

Insights

Securities Analyst

TL;DR Insider proposes a routine sale of RSU-derived shares; prior 10b5-1 trade occurred recently, suggesting planned liquidity rather than ad hoc disposition.

The filing details a proposed disposal of 7,528 Class A shares through Morgan Stanley with an aggregate market value of $590,571.60. Acquisition records show these shares derive from restricted stock unit grants issued between 2021 and 2024. A prior 10b5-1 sale on 05/20/2025 of 23,121 shares produced $1,462,779.51, indicating an active program of scheduled sales. This disclosure is procedural and provides transparency on insider selling but does not convey operational performance.

Compliance/Risk Analyst

TL;DR Filing is a standard Rule 144 notice with required representations; inclusion of 10b5-1 sale supports regulatory compliance.

The Form 144 contains required details: broker, share amounts, acquisition dates, and prior sales, plus the signer’s attestation there is no undisclosed material adverse information. Use of Morgan Stanley and a recorded 10b5-1 sale demonstrates adherence to common compliance channels for insider dispositions. From a governance perspective the filing reduces information asymmetry by publicly documenting planned insider sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	7528	590571.6	168683769	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common Stock	04/21/2021	Restricted Stock Units	Issuer			2328	04/21/2021	N/A
Class A Common Stock	04/27/2022	Restricted Stock Units	Issuer			1746	04/27/2022	N/A
Class A Common Stock	04/18/2023	Restricted Stock Units	Issuer			350	04/18/2023	N/A
Class A Common Stock	07/18/2023	Restricted Stock Units	Issuer			2328	07/18/2023	N/A
Class A Common Stock	05/02/2024	Restricted Stock Units	Issuer			776	05/02/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMES ROGERS 600 WEST CHICAGO AVENUE, Suite 510 CHICAGO IL 60654	Class A Common Stock	05/20/2025	23121	1462779.51

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Tempus AI's (TEM) Form 144 report?

The Form 144 reports a proposed sale of 7,528 Class A common shares via Morgan Stanley on NASDAQ with an aggregate market value of $590,571.60.

Who executed the prior sale disclosed in the filing?

A prior 10b5-1 sale by James Rogers on 05/20/2025 sold 23,121 shares for gross proceeds of $1,462,779.51.

How were the shares being sold acquired?

The shares listed were acquired as Restricted Stock Units (RSUs) on dates between 04/21/2021 and 05/02/2024 in multiple tranches.

Which broker will handle the proposed sale?

The proposed sale is to be handled by Morgan Stanley Smith Barney LLC Executive Financial Services.

Does the filing state any undisclosed material information about Tempus AI?

The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.